我们集团组织了 3000 多个全球系列会议 每年在美国、欧洲和美国举办的活动亚洲得到 1000 多个科学协会的支持 并出版了 700+ 开放获取期刊包含超过50000名知名人士、知名科学家担任编委会成员。
开放获取期刊获得更多读者和引用 700 种期刊 和 15,000,000 名读者 每份期刊 获得 25,000 多名读者
评论
Immunohistochemical Markers and the Clinical Course of Adenosarcoma; A Series of Seven Cases
迷你文章
Tumor necrosis factor-α/CD40 ligand-engineered mesenchymal stem cells greatly Enhanced the antitumor immune response and lifespan in mice
简短的沟通
A neutralizing anti-YKL-40 antibody blocks tumor angiogenesis through binding to an arginine (R) and lysine (K)-rich functional domain of YKL-40
Stroma-derived extracellular vesicles deliver tumor-suppressive mi-RNAs to pancreatic cancer cells
Calcium-activated potassium channels as potential early markers of cervical cancer
社论
Editorial-Market Analysis
Editorial-Announcement